ACTIVE

EVERLAM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result10,8 M €+444,3 %over 1 year

Revenue75,5 M €-1,9 %over 1 year

Equity7 M €+284,0 %over 1 year

Workforce22,1 ETP+16,3 %over 1 year

Identity

Source · BCE/KBO

EVERLAM is a Private limited company incorporated in 2014. Its main activity is: Wholesale of chemical products. Its registered office is in Mechelen. It employs on average 22,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0545.756.444
Incorporation: 31/01/2014
Legal form: Private limited company
Registered office: Blokhuisstraat 47 J
2800 Mechelen · FlandreSee on map
Contributed capital: 12 939 374,00 €
Latest accounts: 31/12/2025
Average workforce: 22,1 ETP

Activities (NACE)

46751Wholesale of chemical products· main 46851Wholesale trade, except of motor vehicles and motorcycles 46900Non-specialised wholesale trade 46900Non-specialised wholesale trade 82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.

Joint committees (1)

Signals

ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 16 filings

Trend over 11 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	75,5 M €	-1.9%	76,9 M €	+36.8%	56,2 M €	-19.0%	69,5 M €	+9.6%	63,4 M €
EBITDA	12,5 M €	+898%	-1,6 M €	+65.9%	-4,6 M €	-26957%	17,1 k €	+130%	-57 k €
Operating result	11,8 M €	+678%	-2 M €	+59.3%	-5 M €	-941%	-483,6 k €	+81.1%	-2,6 M €
Net result	10,8 M €	+444%	-3,1 M €	+44.5%	-5,7 M €	-727%	-684,8 k €	+75.8%	-2,8 M €
Balance sheet
Equity	7 M €	+284%	-3,8 M €	-471%	-666,9 k €	-113%	5 M €	-12.1%	5,7 M €
Total assets	38,7 M €	+15.1%	33,7 M €	-6.6%	36,1 M €	+22.2%	29,5 M €	+5.8%	27,9 M €
Cash	4,8 M €	+11549%	40,9 k €	-92.0%	509,7 k €	-22.9%	660,8 k €	-21.7%	844,4 k €
Debts	31,7 M €	-15.4%	37,5 M €	+2.0%	36,7 M €	+49.8%	24,5 M €	+10.3%	22,2 M €
Other
Workforce	22,1 ETP	+16.3%	19,0 ETP	+11.1%	17,1 ETP	-6.0%	18,2 ETP	-3.7%	18,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 8 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Luc DE TEMMERMAN	Director01/01/2026 → 31/12/2028
Antonie Van Beek	Directorsince 01/07/2023
Hemal Aaron Parekh	Directorsince 05/03/2019
Ian Burke	Directorsince 01/07/2023
Indebom Strategies CommV0501.626.491Represented by Luc De Temmerman	Director01/07/2023 → 12/06/2030
Jaikumar Moorthy	Directorsince 01/07/2023
New Rhein Healthcare Investors0567.570.853Represented by Nayan Gregory Parekh	Directorsince 01/07/2023

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Olivier Demeijer	Director01/12/2022 → 30/06/2023
Olivier Demijer	Director01/12/2022 → 2022 accounts
Albrecht Luick	Director05/03/2019 → 2022 accounts

Other companies at this address

Blokhuisstraat 47 J 2800 Mechelen

Company	CBE no.
Everlam Holding● Active	0662.686.083
Gantrade Europe● Active	0717.995.384

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/06/2026	28/07/2025	19/07/2024	06/09/2023	05/12/2022	23/07/2021
General meeting	10/06/2026	10/07/2025	19/07/2024	30/06/2023	12/07/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	10/06/2026	11/06/2026	Dutch	PDF
Full model	31/12/2024	10/07/2025	28/07/2025	Dutch	PDF
Full model	31/12/2023	19/07/2024	19/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	06/09/2023	Dutch	PDF
Full modelCorrection	31/12/2021	12/07/2022	05/12/2022	Dutch	PDF
Full model	31/12/2021	12/07/2022	14/07/2022	Dutch	PDF
Full model	31/12/2020	18/06/2021	23/07/2021	Dutch	PDF
Full model	31/12/2019	03/07/2020	07/08/2020	Dutch	PDF
Full modelCorrection	31/12/2018	12/06/2019	12/11/2019	Dutch	PDF
Full model	31/12/2018	12/06/2019	01/07/2019	Dutch	PDF
Full model	31/12/2017	13/06/2018	09/07/2018	Dutch	PDF
Full modelCorrection	31/12/2016	14/06/2017	08/12/2017	Dutch	PDF
Full model	31/12/2016	14/06/2017	16/06/2017	Dutch	PDF
Full modelCorrection	31/12/2015	29/06/2016	03/01/2017	Dutch	PDF
Full model	31/12/2015	29/06/2016	07/07/2016	Dutch	PDF
Full model	31/12/2014	26/06/2015	02/07/2015	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

7 active · 8 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Luc DE TEMMERMAN	Director01/01/2026 → 31/12/2028
Antonie Van Beek	Directorsince 01/07/2023
Hemal Aaron Parekh	Directorsince 05/03/2019
Ian Burke	Directorsince 01/07/2023
Indebom Strategies CommV0501.626.491Represented by Luc De Temmerman	Director01/07/2023 → 12/06/2030
Jaikumar Moorthy	Directorsince 01/07/2023
New Rhein Healthcare Investors0567.570.853Represented by Nayan Gregory Parekh	Directorsince 01/07/2023

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Olivier Demeijer	Director01/12/2022 → 30/06/2023
Olivier Demijer	Director01/12/2022 → 2022 accounts
Albrecht Luick	Director05/03/2019 → 2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates09/10/2026
Herbenoeming van de commissaris
PDF
Mandates04/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/02/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/04/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/12/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other28/09/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares30/12/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings11 filings

Mandates

Luc DE TEMMERMAN

Indebom Strategies CommV

New Rhein Healthcare Investors

Ian Burke

Hemal Aaron Parekh

Jaikumar Moorthy

Antonie Van Beek

Olivier Demijer

Olivier Demeijer

Albrecht Luick

Nayan Gregory Parekh

Gregory Parekh

Show the 3 other mandates

201420152016201720182019202020212022202320242025202620272028

EVERLAM

Blokhuisstraat 47 bte J, 2800 Mechelen

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Blokhuisstraat 47 J, 2800 MechelenCurrent		CBE
Blokhuisstraat 47 bte J, 2800 Mechelen	accounts 2021 → 2025	Accounts 2025 · 2026-00166844
Blokhuisstraat 47 J, 2800 Mechelen	accounts 2021	Accounts 2021 · 2022-20202581

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
EVERLAMCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00166844

Events

2025
Annual accounts 202510,8 M €↑
2024
Annual accounts 2024-3,1 M €↑
2023
Annual accounts 2023-5,7 M €↓
2022
Annual accounts 2022-684,8 k €↑
2021
Annual accounts 2021-2,8 M €↑
2020
Annual accounts 2020-4,4 M €↓
2019
Annual accounts 2019-4,2 M €↑
2018
Annual accounts 2018-4,3 M €↑
2017
Annual accounts 2017-6,3 M €↑
2016
Annual accounts 2016-6,9 M €↓
2015
Annual accounts 2015-633,4 k €
31/01/2014
IncorporationPrivate limited company

EVERLAM

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events